Synuca Therapeutics ApS

APSActive

CVR 45367282Ole Maaløes Vej 3, 2200 København NResearch and experimental development on natural sciences and engineering· NACE 7210Est. 2025 · 1 year old2 employees

Overview Financials People & ownership Related companies

Synuca Therapeutics ApS is a Danish APS based in København N, operating in the Research and experimental development on natural sciences and engineering sector. Incorporated in 2025, the company has 2 employees and reported revenue of DKK -256K in its latest annual filing.

Revenue 2025

DKK -256K

EBITDA margin

126.7%

Net profit 2025

DKK -273K

2 employees

Key ratios

See full ratios →

-77.6%

This company

20252025

6.4×

This company

20252025

-79.1%

This company

20252025

EBITDA — year on year

DKK millions

Key figures

Annual report 2025

Revenue	DKK -256K	—
EBITDA	DKK -325K	—
Net profit	DKK -273K	—
Total assets	DKK 345K	—
Equity	DKK -267K	—
Employees	2	—

Contact

Address

Ole Maaløes Vej 3, 2200 København N

Risika for professionals

Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.

Visit risika.com

Frequently asked questions

What is the CVR number of Synuca Therapeutics ApS?

Synuca Therapeutics ApS is registered with CVR / Virk under CVR 45367282.

What is the revenue of Synuca Therapeutics ApS?

Synuca Therapeutics ApS reported revenue of DKK -256K in 2025.

How many employees does Synuca Therapeutics ApS have?

Synuca Therapeutics ApS employs 2 people as of the latest annual report.

Who is the chairman of Synuca Therapeutics ApS?

Anker Gunvald Lundemose chairs the board of Synuca Therapeutics ApS, in role since 2026.

Where is Synuca Therapeutics ApS headquartered?

Synuca Therapeutics ApS's registered address is Ole Maaløes Vej 3.

Synuca Therapeutics ApS

Key ratios

EBITDA — year on year

Key figures

Company information

Contact

Frequently asked questions

More on Synuca Therapeutics ApS

Key ratios

EBITDA — year on year

Key figures

Company information

Contact

Frequently asked questions

More on Synuca Therapeutics ApS